| Serial Number | 97622009 |
| Word Mark | MBL |
| Filing Date | Thursday, October 6, 2022 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Tuesday, September 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of MBL in a stylized blue font with the leg of the "L" curving upward. |
| Goods and Services | Chemical reagents for medical purposes in the fields of cancer, cardiology, autoimmunity and immunological disorders, respiratory diseases, apoptosis, signal transduction, DNA, proteomics and genomics; Reagents for use in medical genetic testing; Immunoassay reagents for medical use; Diagnostic biomarker reagents for medical purposes; Companion diagnostics, namely, medical diagnostic reagents that assist in predicting the effects of a drug, the presence or absence of side effects, and the choice of patients to administer |
| Pseudo Mark | MEDICAL AND BIOLOGICAL LABORATORIES |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| Goods and Services | Testing, analysis and evaluation for approval of goods and services of others to ensure compliance with industry standards; Research and development services in the field of pharmaceutical products; Research and development services in the field of antibodies; Laboratory research services in the field of pharmaceuticals using experimental animals; Cell culture services for scientific and research purposes, for others; Stem cell research services; Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals, in vitro diagnostics, treatment or diagnostics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development support services, namely, pharmaceutical research and development; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, October 23, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, October 23, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Minato-ku, Tokyo 105-0012 JP |
| Event Date | Event Description |
| Monday, October 10, 2022 | NEW APPLICATION ENTERED |
| Sunday, October 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 20, 2023 | ASSIGNED TO EXAMINER |
| Friday, August 4, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, November 6, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 4, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, August 4, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 6, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 6, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 20, 2024 | ASSIGNED TO EXAMINER |
| Friday, April 12, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, January 12, 2024 | FINAL REFUSAL WRITTEN |
| Friday, January 12, 2024 | FINAL REFUSAL E-MAILED |
| Friday, January 12, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, July 12, 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| Friday, July 12, 2024 | EX PARTE APPEAL-INSTITUTED |
| Friday, April 12, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, July 12, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, July 12, 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Tuesday, September 24, 2024 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, September 24, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, September 24, 2024 | SUSPENSION LETTER WRITTEN |